InvestorsHub Logo
Followers 2
Posts 151
Boards Moderated 0
Alias Born 10/24/2016

Re: None

Monday, 10/01/2018 1:42:57 PM

Monday, October 01, 2018 1:42:57 PM

Post# of 1371

News WARNING: MJ BioPharma & Zeus Energy Inc. agreements TERMINATED

This is very bad...! Be CAREFUL guys. Not sure who’s running this OTC, but the Canadian side halted trading over a year ago. Someone is sitting back collecting US investor dollars. Check out this link, where you’ll find updates that American investors were not privy to. Best of luck.

VINERGY RESOURCES LTD.

FORM 51-102F1
MANAGEMENT’S DISCUSSION AND ANALYSIS FOR THE THREE MONTH PERIOD ENDED MAY 31, 2018

Vinergy Resources Ltd. (the “Company”) was incorporated as Vanguard Investments Corp. on March 20, 2001 under the provisions of the Alberta Business Corporations Act. On May 10, 2011, the Company changed its name to Vinergy Resources Ltd. and continued the Company’s registered jurisdiction from Alberta to British Columbia. The Company’s head office is located at Suite 1008, 409 Granville Street, Vancouver, BC, V6C 1T2 and its shares are listed on the Canadian Securities Exchange (“CSE”) under the symbol “VIN”

On November 30, 2009, the Company entered into a Share Purchase Agreement (the “Agreement”) with Zeus Energy Inc. (“Zeus”) and its shareholders to acquire 100% of the issued and outstanding shares of Zeus. Zeus was incorporated on November 7, 2007 under the Alberta Business Corporations Act. Since the closing of the Agreement on November 30, 2009, the Company has been in the business of oil and gas acquisition, exploration and development. On May 2, 2017 Zeus Energy Inc. was discontinued.

On May 8, 2017 (as amended), the Company entered into a share exchange agreement (the “Agreement”) with 1099955 B.C. Ltd. (“MJ BioPharma”) a private British Columbia company. Pursuant to the terms of the Agreement, the Company will acquire 100% of the issued and outstanding securities of MJ BioPharma by issuing 4,000,000 common shares of the Company to the shareholders of MJ BioPharma. The Company will issue 400,000 common shares as a finder’s fee on the closing of the transaction. The Agreement is subject to regulatory approval. The Agreement was cancelled on April 19, 2018.

https://www.sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00016546